"The
Report PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and
Market Analysis to 2025 provides information on pricing, market
analysis, shares, forecast, and company profiles for key industry
participants. MarketResearchReports.biz”
A new market research report
has been added by MarketResearchReports.biz to its vast repository of
research studies. The 235-page, research study, titled “PharmaPoint:
Psoriatic Arthritis -
Global Drug Forecast and Market Analysis to 2025,” offers a
complete overview of the market, highlighting the key growth factors
that are anticipated to influence the development in the next few
years. The promising growth opportunities for the key players and the
challenges being faced by them have been included in the scope of the
study to provide a clear understanding of the global psoriatic
arthritis market. As per the study, the market is expected to
register a progressive 10.74% CAGR between 2016 and 2025.
The changing lifestyle patterns
and the rising patient population are some of the key factors that
are likely to encourage the growth of the global psoriatic arthritis
market in the next few years. In addition, the rising awareness among
consumers regarding psoriatic arthritis and the availability of drugs
and treatments are estimated to accelerate the growth of the market
in the forecast period. On the contrary, the rising cost of
biologics, adverse side-effects of drugs, and the use of CAM by
patients are projected to curb the growth of the global psoriatic
arthritis market in the coming years.
Furthermore, the introduction
of biosimilars and the increasing popularity of traditional and
off-label treatment options are anticipated to accelerate the growth
of the global psoriatic arthritis market in the coming years. In
addition, the emergence of patient assistance programs, especially in
developed regions are projected to create promising opportunities for
key players operating in the market across the globe.
According to the study, North
America is expected to experience a high growth throughout the
forecast period. This region is expected to remain in the leading
position and account for a key share of the overall market in the
next few years. A significant rise in the consumer awareness
regarding the therapeutics and the launch of assistance programs are
projected to supplement the growth of the market in North America in
the next few years. The share, size, and the anticipated growth rate
of each regional segment have been given in the research study to
offer a strong understanding of the market.
View Press Release @
http://www.marketresearchreports.biz/pressrelease/4102
The global market for psoriatic
arthritis is highly competitive in nature, thanks to the presence of
a large number of players across the globe. The expansion of the
product portfolio and the presence of a strong pipeline are some of
the key factors that are likely to encourage the growth of the
overall market in the next few years. Some of the key players
operating in the psoriatic arthritis market across the globe are
AbbVie, Pfizer, AstraZeneca, Bristol-Myers Squibb, Celgene, Eli
Lilly, Johnson & Johnson, Novartis, Amgen, Alder, and UCB.
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment